Industry needs to broaden the talent bridge into biopharma

Overcoming biopharma’s talent crunch will require companies to make themselves more visible, accessible and instructive to new entrants, and counteract inequalities in exposure to industry. 

Academia’s acceptance of biopharma careers is growing, and it has grown well beyond viewing industry as “the dark side,” but the range of possible professions, especially those beyond the bench, is largely opaque to students and postdocs. ...